This is the authors' abstract. We don't add key points for this paper.
The biological activity of the glycoprotein hormone erythropoietin (EPO) is dependent mainly on the structure of its N-linked glycans. We aimed to readily attach defined N-glycans to EPO through copper-catalyzed azide alkyne cycloaddition. EPO variants with an alkyne-bearing non-natural amino acid (Plk) at the N-glycosylation sites 24, 38, and 83 were obtained by amber suppression followed by protein purification and refolding. Click conjugation of the alkynyl EPOs with biantennary N-glycan azides provided biologically active site-specifically modified EPO glycoconjugates.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Streichert et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: